Healthcare Industry News: Wright Medical Group
News Release - April 5, 2007
Wright Medical Completes Acquisition of DARCO International, Inc. Reconstructive Foot Surgery BusinessAcquisition Substantially Expands Wright's Foot and Ankle Reconstructive Portfolio
ARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ), announced today that it has completed its acquisition of substantially all the assets of Darco International, Inc.'s reconstructive foot surgery line of business for approximately $17 million in cash.
Darco's reconstructive product line consists of a broad offering of procedure-specific plating systems designed with leading foot surgeons, including the MRS (Modular Rearfoot), MFS (Modular Forefoot) and FRS (Forefoot Reconstructive) Systems. These three systems offer a combined ten different plating options and specialized screw fixation systems for use in advanced reconstructive foot procedures. Darco's reconstructive foot surgery business generated net sales of approximately $6 million in 2006 with the majority of these sales occurring in Germany where Darco is the market leader in foot and ankle reconstructive implants. With the acquisition now complete, Wright has initiated the commercial launch of the DARCOŽ reconstructive portfolio into the U.S. foot and ankle marketplace. The combination of the DARCOŽ procedure-specific plating systems with the Company's line of other products and biologic solutions enables Wright to offer the broadest portfolio of foot and ankle products in the industry.
As previously announced, this acquisition is expected to be neutral to Wright's adjusted earnings, which exclude acquisition-related costs such as integration charges and non-cash inventory step-up expenses, during the remainder of 2007, and accretive to Wright's earnings thereafter. More detailed guidance regarding the financial aspects of the transaction and its expected impact on Wright's future financial results will be provided in connection with the Company's announcement of its first quarter 2007 financial results on April 30, 2007.
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide.
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2006 under the heading, "Risk Factors" and its quarterly reports), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Source: Wright Medical Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.